Decreased expression and the Lys751Gln polymorphism of the XPD gene are associated with extreme longevity

被引:20
|
作者
Polosak, Jacek [1 ]
Roszkowska-Gancarz, Malgorzata [1 ]
Kurylowicz, Alina [2 ]
Owczarz, Magdalena [3 ]
Dobosz, Paulina [1 ]
Mossakowska, Malgorzata [3 ]
Szybinska, Aleksandra [3 ]
Puzianowska-Kuznicka, Monika [1 ,2 ]
机构
[1] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, PL-01813 Warsaw, Poland
[2] Polish Acad Sci, Med Res Ctr, Dept Endocrinol, PL-02106 Warsaw, Poland
[3] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland
关键词
Aging; Centenarians; Longevity; Xeroderma pigmentosum complementation group D gene (XPD); Genetic polymorphism; Expression; Promoter methylation; NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; XERODERMA-PIGMENTOSUM; ESOPHAGEAL ADENOCARCINOMA; CANCER-RISK; LIFE-SPAN; CHROMOSOMAL-ABERRATIONS; NITRIC-OXIDE; SUPEROXIDE; AGE;
D O I
10.1007/s10522-009-9246-y
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Aging is associated with progressing genomic instability. The XPD gene encodes a DNA helicase involved in nucleotide excision repair and in transcription. We analyzed the common XPD polymorphisms that were previously shown to affect protein's DNA repair efficiency and to increase the risk of developing various cancers. Analysis was performed in 149 centenarians (mean age 101.1 years old) and in 413 young subjects (mean age 27.1 years old). We showed that the distribution of the Lys751Gln genotypes differed significantly between these groups (P = 0.017). In centenarians, the homozygous genotypes AA and CC were found less frequently than in young controls (29 vs. 36%, OR = 0.71, and 14 vs. 20%, OR = 0.652, respectively). The Arg156Arg and Asp312Asn were not significantly associated with extreme longevity. Analysis of the XPD mRNA level in blood mononuclear cells of people divided into three age groups (mean ages 28.7, 65.8 and 92.7 years old) showed that extreme longevity is associated with the decrease of the mean level of the specific mRNA; the differences between young or middle-aged vs. extremely old group were significant (P < 0.0001, P < 0.0001, respectively). In addition, the methylation pattern of the XPD promoter was analyzed in 30 people divided into three age groups (29.5, 65.9, and 101.4 years old). We showed that overall methylation of the XPD promoter is a rare event; however, aging is associated with the increase of methylation level upstream of the transcription start site. In summary, we showed for the first time that both the XPD polymorphic variants and the decreased level of its expression might be associated with aging.
引用
收藏
页码:287 / 297
页数:11
相关论文
共 50 条
  • [21] ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians
    Zhang, Jian
    Gu, Shi-Yang
    Zhang, Ping
    Jia, Zhen
    Chang, Jian-Hua
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (13) : 2479 - 2484
  • [22] Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
    Lin, Hai
    Lin, Dong
    Zheng, Chunquan
    DIAGNOSTIC PATHOLOGY, 2014, 9
  • [23] XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects
    Li-Xin Qiu
    Lei Yao
    Jian Zhang
    Xiao-Dong Zhu
    Xin-Min Zhao
    Kai Xue
    Chen Mao
    Bo Chen
    Ping Zhan
    Hui Yuan
    Xi-Chun Hu
    Breast Cancer Research and Treatment, 2010, 124 : 229 - 235
  • [25] XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects
    Qiu, Li-Xin
    Yao, Lei
    Zhang, Jian
    Zhu, Xiao-Dong
    Zhao, Xin-Min
    Xue, Kai
    Mao, Chen
    Chen, Bo
    Zhan, Ping
    Yuan, Hui
    Hu, Xi-Chun
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (01) : 229 - 235
  • [26] XPD Lys751Gln polymorphism and esophageal cancer risk: A meta-analysis involving 2288 cases and 4096 controls
    Yuan, Ling
    Cui, Dan
    Zhao, Er-Jiang
    Jia, Chen-Zhi
    Wang, Li-Dong
    Lu, Wei-Quan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (18) : 2343 - 2348
  • [27] No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk
    David-Beabes, GL
    Lunn, RM
    London, SJ
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (08) : 911 - 912
  • [28] Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
    Hai Lin
    Dong Lin
    Chunquan Zheng
    Diagnostic Pathology, 9
  • [29] No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis
    Poletto, Valentina
    Villani, Laura
    Catarsi, Paolo
    Campanelli, Rita
    Massa, Margherita
    Vannucchi, Alessandro M.
    Rosti, Vittorio
    Barosi, Giovanni
    HAEMATOLOGICA, 2013, 98 (08) : E83 - E84
  • [30] XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia:: a Children's Oncology Group report
    Mehta, PA
    Alonzo, TA
    Gerbing, RB
    Elliott, JS
    Wilke, TA
    Kennedy, RJ
    Ross, JA
    Perentesis, JP
    Lange, BJ
    Davies, SM
    BLOOD, 2006, 107 (01) : 39 - 45